Cargando…
Targeted Endocrine Agents should be the Dominant Systemic Therapies Prescribed in Luminal A Breast Cancer
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
SAGE Publications
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9841871/ https://www.ncbi.nlm.nih.gov/pubmed/36654912 http://dx.doi.org/10.1177/11782234221145409 |
| _version_ | 1784869991710982144 |
|---|---|
| author | Davey, Matthew G Kerin, Michael J |
| author_facet | Davey, Matthew G Kerin, Michael J |
| author_sort | Davey, Matthew G |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9841871 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | SAGE Publications |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-98418712023-01-17 Targeted Endocrine Agents should be the Dominant Systemic Therapies Prescribed in Luminal A Breast Cancer Davey, Matthew G Kerin, Michael J Breast Cancer (Auckl) Commentary SAGE Publications 2023-01-13 /pmc/articles/PMC9841871/ /pubmed/36654912 http://dx.doi.org/10.1177/11782234221145409 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by-nc/4.0/This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License (https://creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access page (https://us.sagepub.com/en-us/nam/open-access-at-sage). |
| spellingShingle | Commentary Davey, Matthew G Kerin, Michael J Targeted Endocrine Agents should be the Dominant Systemic Therapies Prescribed in Luminal A Breast Cancer |
| title | Targeted Endocrine Agents should be the Dominant Systemic Therapies Prescribed in Luminal A Breast Cancer |
| title_full | Targeted Endocrine Agents should be the Dominant Systemic Therapies Prescribed in Luminal A Breast Cancer |
| title_fullStr | Targeted Endocrine Agents should be the Dominant Systemic Therapies Prescribed in Luminal A Breast Cancer |
| title_full_unstemmed | Targeted Endocrine Agents should be the Dominant Systemic Therapies Prescribed in Luminal A Breast Cancer |
| title_short | Targeted Endocrine Agents should be the Dominant Systemic Therapies Prescribed in Luminal A Breast Cancer |
| title_sort | targeted endocrine agents should be the dominant systemic therapies prescribed in luminal a breast cancer |
| topic | Commentary |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9841871/ https://www.ncbi.nlm.nih.gov/pubmed/36654912 http://dx.doi.org/10.1177/11782234221145409 |
| work_keys_str_mv | AT daveymatthewg targetedendocrineagentsshouldbethedominantsystemictherapiesprescribedinluminalabreastcancer AT kerinmichaelj targetedendocrineagentsshouldbethedominantsystemictherapiesprescribedinluminalabreastcancer |